The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ABIVAX SA | SPONSORED ADS | 00370M103 | 16,585,000 | 1,550,000 | SH | DFND | 1,2 | 0 | 1,550,000 | 0 | ||
AEROVATE THERAPEUTICS INC | COM | 008064107 | 23,482,925 | 1,037,690 | SH | DFND | 1,2 | 0 | 1,037,690 | 0 | ||
ALKERMES PLC | SHS | G01767105 | 24,273,721 | 875,044 | SH | DFND | 1,2 | 0 | 875,044 | 0 | ||
ALPINE IMMUNE SCIENCES INC | COM | 02083G100 | 70,587,433 | 3,703,433 | SH | DFND | 1,2 | 0 | 3,703,433 | 0 | ||
AMICUS THERAPEUTICS INC | COM | 03152W109 | 18,170,295 | 1,280,500 | SH | DFND | 1,2 | 0 | 1,280,500 | 0 | ||
ANAPTYSBIO INC | COM | 032724106 | 20,926,933 | 976,981 | SH | DFND | 1,2 | 0 | 976,981 | 0 | ||
APOGEE THERAPEUTICS INC | COM | 03770N101 | 11,176,000 | 400,000 | SH | DFND | 1,2 | 0 | 400,000 | 0 | ||
ARCELLX INC | COMMON STOCK | 03940C100 | 2,678,652 | 48,264 | SH | DFND | 1,2 | 0 | 48,264 | 0 | ||
ARVINAS INC | COM | 04335A105 | 9,634,815 | 234,082 | SH | DFND | 1,2 | 0 | 234,082 | 0 | ||
AXSOME THERAPEUTICS INC | COM | 05464T104 | 395,005 | 4,963 | SH | DFND | 1,2 | 0 | 4,963 | 0 | ||
CYTOKINETICS INC | COM NEW | 23282W605 | 41,745,000 | 500,000 | SH | DFND | 1,2 | 0 | 500,000 | 0 | ||
EVOLUS INC | COM | 30052C107 | 21,060,000 | 2,000,000 | SH | DFND | 1,2 | 0 | 2,000,000 | 0 | ||
IMMUNOCORE HLDGS PLC | ADS | 45258D105 | 20,017,760 | 293,000 | SH | DFND | 1,2 | 0 | 293,000 | 0 | ||
INSMED INC | COM PAR $.01 | 457669307 | 7,001,013 | 225,912 | SH | DFND | 1,2 | 0 | 225,912 | 0 | ||
INTRA-CELLULAR THERAPIES INC | COM | 46116X101 | 7,921,673 | 110,607 | SH | DFND | 1,2 | 0 | 110,607 | 0 | ||
KARUNA THERAPEUTICS INC | COM | 48576A100 | 9,574,428 | 30,250 | SH | DFND | 1,2 | 0 | 30,250 | 0 | ||
MERUS N V | COM | N5749R100 | 550,000 | 20,000 | SH | DFND | 1,2 | 0 | 20,000 | 0 | ||
MURAL ONCOLOGY PUB LTD CO | ORD SHS | G63365103 | 68,133 | 11,509 | SH | DFND | 1,2 | 0 | 11,509 | 0 | ||
NEUROGENE INC | COM | 64135M105 | 19,268,158 | 994,229 | SH | DFND | 1,2 | 0 | 994,229 | 0 | ||
OCULAR THERAPEUTIX INC | COM | 67576A100 | 3,122,000 | 700,000 | SH | DFND | 1,2 | 0 | 700,000 | 0 | ||
OPTINOSE INC | COM | 68404V100 | 11,403,521 | 8,839,939 | SH | DFND | 1,2 | 0 | 8,839,939 | 0 | ||
PLIANT THERAPEUTICS INC | COM | 729139105 | 33,017,862 | 1,823,184 | SH | DFND | 1,2 | 0 | 1,823,184 | 0 | ||
PUMA BIOTECHNOLOGY INC | COM | 74587V107 | 4,733,872 | 1,093,273 | SH | DFND | 1,2 | 0 | 1,093,273 | 0 | ||
RAPT THERAPEUTICS INC | COM | 75382E109 | 27,328,862 | 1,099,753 | SH | DFND | 1,2 | 0 | 1,099,753 | 0 | ||
SAREPTA THERAPEUTICS INC | COM | 803607100 | 7,714,400 | 80,000 | SH | DFND | 1,2 | 0 | 80,000 | 0 | ||
SPYRE THERAPEUTICS INC | COM NEW | 00773J202 | 2,690,000 | 125,000 | SH | DFND | 1,2 | 0 | 125,000 | 0 | ||
TERNS PHARMACEUTICALS INC | COM | 880881107 | 8,501,738 | 1,309,975 | SH | DFND | 1,2 | 0 | 1,309,975 | 0 | ||
TOURMALINE BIO INC | COM | 89157D105 | 17,616,129 | 672,885 | SH | DFND | 1,2 | 0 | 672,885 | 0 | ||
ULTRAGENYX PHARMACEUTICAL IN | COM | 90400D108 | 30,987,360 | 648,000 | SH | DFND | 1,2 | 0 | 648,000 | 0 | ||
UROGEN PHARMA LTD | COM | M96088105 | 39,308,175 | 2,620,545 | SH | DFND | 1,2 | 0 | 2,620,545 | 0 | ||
VAXCYTE INC | COM | 92243G108 | 22,608,000 | 360,000 | SH | DFND | 1,2 | 0 | 360,000 | 0 | ||
VISTAGEN THERAPEUTICS INC | COM | 92840H400 | 9,553,898 | 1,858,735 | SH | DFND | 1,2 | 0 | 1,858,735 | 0 | ||
XENON PHARMACEUTICALS INC | COM | 98420N105 | 27,636,000 | 600,000 | SH | DFND | 1,2 | 0 | 600,000 | 0 | ||
ZURA BIO LTD | CLASS A ORD SHS | G9TY5A101 | 15,387,650 | 3,295,000 | SH | DFND | 1,2 | 0 | 3,295,000 | 0 |